Statin treatment and cerebral microbleeds: A risk assessment

Katsanos et al. conducted a meta-analysis to investigate the association between statin treatment and cerebral microbleeds (CMBs) [1]. The adjusted odds ratios (95% confidence intervals [CIs]) of statin treatment for all- and lobar CMBs were 1.09 (0.64 –1.86) and 2.26 (0.86–5.91), respectively. As there was a heterogeneity in this analysis, the authors recommended further investigation. I have a comment regarding the study.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Letter to the Editor Source Type: research